Topical creams are becoming part of the mix of pain treatment options as doctors look for alternatives to addictive opioids.
The Enlyte Drug Trends Report has uncovered a lot important information regarding changes in pharmacy spend and utilization. To discuss highlights from part 3 of the report, we welcome back Nikki Wilson, Senior Director, Clinical Pharmacy Services and Solutions at Enlyte.
In this article we will discuss what biological and biosimilar drugs are, what makes them different from conventional drugs, and specific examples related to workers’ comp.
A national insurance carrier had a decentralized claim handling model with five vendors providing bill review services.
This video explores these vocational challenges in depth. Gain the insights you need to support the journey back to work.
Nikki Wilson, Pharm.D./MBA, discusses some of the particular challenges for pharmacies in the face of the nation's ongoing opioid epidemic and offers insight on how to handle them.
A new series of reports from Enlyte analyzing pharmacy spend and utilization data from 2022 reveals that topicals have surpassed opioids in overall cost, though pharmacy costs and utilization have remained relatively stable.